Log in to save to my catalogue

Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Ato...

Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Ato...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce853be90c77442287117f0a76d2bc18

Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis

About this item

Full title

Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis

Publisher

Basel: MDPI AG

Journal title

Life (Basel, Switzerland), 2021-09, Vol.11 (9), p.927

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Background: Some Network Meta-analysis (NMA) has been published regarding atopic dermatitis (AD). These studies have considered drugs under investigation both in monotheraphy or in combination with topical corticosteroids, as well as systemic immunosuppressant therapies. The objective of this study is to evaluate the efficacy and safety of biologic...

Alternative Titles

Full title

Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ce853be90c77442287117f0a76d2bc18

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce853be90c77442287117f0a76d2bc18

Other Identifiers

ISSN

2075-1729

E-ISSN

2075-1729

DOI

10.3390/life11090927

How to access this item